Lipodystrophic Nonalcoholic Fatty Liver Disease Induced by Immune Checkpoint Blockade
- 16 June 2020
- journal article
- letter
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 172 (12), 836-+
- https://doi.org/10.7326/L19-0635
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trialThe Lancet HIV, 2019
- Immune-Related Adverse Events Associated with Immune Checkpoint BlockadeNew England Journal of Medicine, 2018
- Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in HumansCell Metabolism, 2017
- PPARγ signaling and metabolism: the good, the bad and the futureNature Medicine, 2013
- Genetic determinants of hepatic steatosis in manJournal of Lipid Research, 2011